chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Jynneos vaccine was given intramuscularly in the deltoid instead of subcutaneously; Case reference number US-BN-2022-004760 is a spontaneous case report initially received on 29-Nov-2022 from other health professional via Communications (reference number: USBAV22-2015) and concerns a patient of unknown demographics.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, the patient was vaccinated with a dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating, batch number: unknown), at an unknown dose, intramuscularly in the deltoid (explicitly coded as 'inappropriate route of vaccination'), for an unknown indication.  At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccination.  Additional information received from Bavarian Nordic on 29-Nov-2022 included the local BN case ID.; Reporter's Comments: A patient of unknown demographics was vaccinated with a dose of Jynneos vaccine at an unknown dose, intramuscularly in the deltoid for an unknown indication, which is considered as inappropriate route of vaccination. No associated adverse events were reported. Inappropriate route of vaccination is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate route of vaccination is not related to Jynneos, but to a human factor. The case is non-serious.; Sender's Comments: A patient of unknown demographics was vaccinated with a dose of Jynneos vaccine at an unknown dose, intramuscularly in the deltoid for an unknown indication, which is considered as inappropriate route of vaccination. No associated adverse events were reported. Inappropriate route of vaccination is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate route of vaccination is not related to Jynneos, but to a human factor. The case is non-serious.
Client experience dizziness.  Client was evaluated by onsite paramedic and released to ho home at 9:57 am.
Vaccine was administered to (L) thigh but moved during the procedure. On 8/9/19 he developed a fever to 103.1 24 hours after vaccine was given. On 8/10/19 the grandmother noticed redness around the injection site. Pt was prescribed Omnicef for 10 days. Mother may apply Benadryl topical cream if pt has itching @ this site.
Patients experienced inflammation where previous filler (Restylane) was injected following COVID vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE INFLAMMATION (Patients experienced inflammation where previous filler (Restylane) was injected following COVID vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYALURONIC ACID (RESTYLANE) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE INFLAMMATION (Patients experienced inflammation where previous filler (Restylane) was injected following COVID vaccination). At the time of the report, INJECTION SITE INFLAMMATION (Patients experienced inflammation where previous filler (Restylane) was injected following COVID vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Woke up during the night (12/24) with a sore throat, felt like it was closing and called 911. Did not go to ER. took Benadryl with relief. Injection site hot with an  extremely sore arm the first day which is better now. Fatigue, achy all over persists taking tylenol and ibuprofen for symptoms.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 06-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported. Reporter had stated that the vial had been moved from frozen to refrigerated storage when they received them on 30Aug2021.
rash on chest that is erythematous and warm to her chest. It started 3 days after receiving the covid vaccine and has continued the next day to spread despite trying topical benadryl cream.
Incorrect immunization given to patient. Patient was given HPV (Gardasil 9) instead of PPSV 23.
The patient presented to clinic for routing visit and was due for Hepatitis B vaccine; however, the MA vaccinated the patient with the pediatric dose versus adult dose. The vaccine was given at 11:15 to the right deltoid, and patient tolerated well with no signs or symptoms of any adverse effects
Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/26 pt cc: cough, fever, loss of taste or smell. dyspnea, exposure: unknown 08/27 SARS-COV-2 Variant Sequencing result: pending 09/07 COVID swab, result: detected 09/09 CXR impression: No acute cardiopulmonary process is detected 09/09 pt admit cc: cp dx: hauler syndrome LOS: 1 day 09/23 COVID swab, result: not detected
Shingles on right side of forehead.  Pain began about a week after first COVID-19 shot but rash didn't appear until around midday on April 3.
Inflammatory rash at injection site. Treatment: Neosporin/HCBID.
painful site of injections; Deltoid muscle is sore anytime it's moved; This is a spontaneous report from a non-contactable consumer or other non hcp (patient herself). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 10Apr2021 09:30 (at the age of 49 years old; Batch/Lot number; Expiration date was not reported) as first dose, single dose and via an unspecified route of administration, administered in the right arm on 29Apr2021 17:30 (at the age of 49 years old; Batch/Lot number; Expiration date was not reported) as second dose, single dose, both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took metronidazole. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced 19 days post vaccine still painful site of injections and deltoid muscle is sore anytime it's moved on an unspecified date in Apr2021. Treatment was not received as a result of the events. Events resulted to doctor clinic visit. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
"My left arm near by triceps became sore. I didn't think anything of it until the pain/sensitivity work me up at midnight. I had a dull ache, and the skin was really sensitive. I took a Benadryl and got through the night sleeping, but Saturday I experience continued aches and skin sensitivity (couldn't touch my underarm) skin heat and swelling."
Whole left side of arm was swollen; Felt so cold; Feeling gassy; She could not open her hand or grab something; Fever; Fatigue; Chills; Headache; Joint pain; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Whole left side of arm was swollen), FEELING COLD (Felt so cold), FLATULENCE (Feeling gassy), MUSCULAR WEAKNESS (She could not open her hand or grab something) and PYREXIA (Fever) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PERIPHERAL SWELLING (Whole left side of arm was swollen), FEELING COLD (Felt so cold), FLATULENCE (Feeling gassy), MUSCULAR WEAKNESS (She could not open her hand or grab something), PYREXIA (Fever), FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On 26-Apr-2021, PERIPHERAL SWELLING (Whole left side of arm was swollen), FEELING COLD (Felt so cold), FLATULENCE (Feeling gassy), MUSCULAR WEAKNESS (She could not open her hand or grab something), PYREXIA (Fever), FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided. No relevant concomitant medications reported.
pt recv vax & JUN97 pt devel right sided pneumonia & rt pleural emphysema;pt hosp & treated w/IV cephalosporins;cult was sterile or negative;cult pleuritic drainage positive for H. influenzae type b;
mild flu-like symptoms; diarrhea; loss of appetite; vomiting; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting) and NAUSEA (nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037H201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (fatigue). On 20-Jan-2021, INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient should have received Tdap instead patient received DAPTACEL dtap. No currently reported adverse events experienced by the patient.
I noticed I was really fatigued and slow. I had chills and fever (102) with nausea.
poss sz; staring episode arms & legs stiff & straight 30 sec; lt eye turned in, rt straight lasting 1-2 min a/eyes followed;
Pt did not respond to vax series; 14FEB92 HBSAB neg; 3 booster doses were given; subsequent titers 31JUN91 & 24OCT91 p/booster doses were neg;
Pt developed rash on both legs, upper thigh to knee. Symptoms started on 2/17/00. No fever or swelling was noted.
I noticed I began having symptoms around 4/5/2021. I had sore legs, sore hips, and a sore back. My left shoulder was also sore; this is the shoulder where I was injected with the Moderna. I went to the doctor when my right knee began hurting. I also told him about the widespread muscle soreness I had been experiencing, but he shrugged it off. I'm 73 years old, so muscle pains are probably common at my age. He said there was nothing physically wrong with my knee, but he gave me methylprednisolone. The methylprednisolone really helped with the pain, though I still have stiffness in my lower back, hips, thighs, and right knee. Having said that, though, the right knee is now doing better than before.
SkinRash & UrticariaPruritus Narrative:  Other Relevant History:
Fever: 99.5, 100.0, 100.6. Body aches. Body sensitivity. Headache. Fatigue.  Pain in injection area. Redness in injection area.
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from their freezer/they were administered to 118 patients.) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer). On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was an excursion from their freezer/they were administered to 118 patients.). On 01-Oct-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer) had resolved. On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (There was an excursion from their freezer/they were administered to 118 patients.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided  On 01-Oct-2021, There was temperature excursion from  freezer.   It was stated 10 Number of vials/doses were impacted. Storage condition at the time of the excursion was frozen and Minimum temperatures reached 4.2 degrees F and maximum was 5.7 degreed F and Excursion duration was 6 minutes.  No treatment medications were provided.    Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Follow-up received which included  patient details (initials, age, gender) and vaccine information ( date of vaccination, dose number).
Patient received # 2 Hep B shot on 7/7/16. Arm (L) became sore on first day and very sore on 2nd day. When she received shot # 1 (on 5/26/16) her arm also was sore. The night of day two she felt aching in her legs-cramps-unable to straighten legs. Became increasingly fatigued. Began to feel better after 3 days. On 7/12/16 she was diagnosed with pneumonia. Does have a documented sensitivity to Hep A vaccine.
Chills; Nausea; Headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy (sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included linaclotide (LINZESS) and blood pressure medications (MANUFACTURER UNKNOWN) for unknown indications from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 14:00, the patient experienced chills, nausea, headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, nausea, headache and diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
shot did not hurt at all, arm wasn't sore. the next day my arm started itching and i scratched it. then the next day the arm was red and itching. Went to the dr on the 01/29/2021 and was given Benadryl and Antibiotic, Then it started to get better
Site of injection painful and warm to touch. Extreme fatigue. Slight nausea. Very brief temperature spikes. Aching joints. Needed to take a day and a half off from work. Took ibuprofen at regular intervals as recommended on the bottle. By the morning of August 24, 2018 felt well enough to return to work. The only continuing symptom was the soreness at the injection site which was still warm to the touch.
After administering vaccines (Hep. A, Varicella, MCV4, and HPV) the patient became ligtheaded and fainted.  She was change from a sitting to a lying position, her blood pressure was taken (BP=90/57, HR=56).  She was monitored for an additonal 10-15 minutes and left the clinic in stable condition.
Extreme pain in my arm, to the point where I felt that arm was disabled, pain redness and swelling. Then I had flu like sypmtoms and nausea and had extreme fatigue and weakness, where I required assistance to ambulate.  I could not get out from under the covers by myself. I also had muscle pain, I had a fever.  I had waves of chills, Even before nausea set in I had no appetite for anything. I had some vomitting, more like dry heaving. The last thing I experienced was a headache.  It was very tramatic. I remember I started crying and I felt like I was dying.
Zero pain with injection. Immediately upon the needle leaving my arm I began to feel dizzy and really weak. Thought I was going to pass out but didn?t . My tongue felt funny almost electric.  Then my heart took off and raced for a good bit.  Just felt really washed out.  It was a drive through clinic we did not alert anyone. Felt my husband would get someone if I passed out. Felt really tired for the rest of the day and had heart palpitations throughout the following week.  I?m now fine. Called in to my primary and they advised I should report
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On 16-FEB-2016, the patient was inadvertently administered an expired dose of ZOSTAVAX lot # K020801, exp. 31-JAN-2016 (dose, route and site of administration were not reported). There was no adverse effects reported. Additional information has been requested.
Shot was given on Wednesday late afternoon or early evening.  By following morning I had a severely sore scratchy throat, painful sinus pressure, headache, dizziness, and extreme fatigue.  I slept most of the day Thursday, Friday, Saturday and Sunday. By late afternoon on Monday I began to feel some what better.
Initial report received from a health care professional on 26 January 2011.  A 10-year-old male child received on 04 October 2010 an intramuscular injection (site not reported) of FLUZONE SV 2010-2011, lot number U3655AA.  The patient had no medical history, takes no concomitant medications, had no illness at the time of vaccination, had no other vaccinations within 4 weeks of the FLUZONE and had no adverse events following prior vaccinations.  On 26 January 2011, the patient required a doctor visit where a Quidel QuickVue test for influenza resulted in a positive test for A & B.  The outcome was reported as not recovered.  The reporter is the same as case 2011-000392.  Documents held by sender: None.
Approx 3-4 hours after receiving flu shot I began bleeding.  Followed up with my OBGYN for miscarriage.  Later diagnosed as Gestational Trophoblastic Disease and referred to oncologist.
A knot the size of a half dollar developed at the injection site a week and a day after the vaccine It was EXTREMELY itchy.... so much that I put Cortisone 10 on it for relief. It also looked bruised. What was shocking to me that absolutely no side effects up until that point. Today, Monday, the knot is still there, it is not as itchy and it is still bruised looking.
Filing the form on behalf of patient complaint from vaccination received in 2013/10/24. Patient reports "shaking violently", to pharmacy corporate on 4/21/15.
developed some nodules under his arm; afraid of these "nodules"; probably muscle pain; When he touched under his arm, it hurt; This spontaneous case was reported by a consumer and describes the occurrence of NODULE (developed some nodules under his arm), TENSION (afraid of these "nodules"), MYALGIA (probably muscle pain) and AXILLARY PAIN (When he touched under his arm, it hurt) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NODULE (developed some nodules under his arm), TENSION (afraid of these "nodules"), MYALGIA (probably muscle pain) and AXILLARY PAIN (When he touched under his arm, it hurt). At the time of the report, NODULE (developed some nodules under his arm), TENSION (afraid of these "nodules"), MYALGIA (probably muscle pain) and AXILLARY PAIN (When he touched under his arm, it hurt) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2021-328758 (Patient Link).
A serious, spontaneous report of status epilepticus, dehydration and fever was received from a physician, concerning a 36-month-old male subsequent to FLUMIST.  The patient's past medical history includes neuromuscular disorder, cerebral palsy, seizure and microcephaly.  Concomitant medications included anti-epileptic medication.  A week prior to vaccination the patient had a runny nose and congestion.  The patient received FLUMIST on 15-Oct-2008 for vaccination.  On 17-Oct-2008, the patient presented with a fever of 38.1 degrees Celsius.  On 18-Oct-2008 the patient was admitted to the hospital with dehydration and status epilepticus and was intubated.  During routine surveillance of sick children, CDC analysis of samples from this patient revealed Influenza type B, which proved to be FLUMIST type B.  The reporter stated that the events would be reported to VAERS.  The patient recovered on an unknown date.
First symptom severe joint pain ~ trouble walking in clinic parking lot. Over next 24- 72 hours temperature over 102 degrees. Chills. Increase respiration and talking oddly. Severe aches. Headache. Continued joint pain. Felt like heavy weight on chest. Chest congested happened at about 72 hours. I a still weak. The symptoms are very difficult. Please note that I had the extra strength over age 65 vaccination. Not still fully recovered ~ weakness. I suspect by next week I will be back to normal.
Adverse effect of other vaccines and biological substances, initial encounter on 2022-01-03.